UTI Healthcare Fund-Growth Option- Direct

Very High Risk
Equity
Sector - Healthcare

NAV as on Oct 23, 2026

Price per unit of the scheme.

₹ 354.6417-0.77%1 Day Change

-10.22%

Minimum Investment₹5000

Expense Ratio1.45%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

*Morningstar Rating Methodology i

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions

FUND PERFORMANCE

As On Jan 01, 2023

Compare fund’s performance against category average across different time periods

No Data Found.

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

FUND COMPARISON

1M 3M 6M 1Y 3Y 5Y

This Fund

UTI Healthcare Fund-Growth Option- Direct

Equity: Sector - Healthcare Average NAV

Topper in Equity: Sector - Healthcare

All Fund

No Data Found.

*For the other fund, rescaled NAVs are used

RETURN CALCULATOR

Check the return on your investment in the fund

UTI Healthcare Fund-Growth Option- Direct

Investment Type

Monthly Investment

Time Period (yrs)

Annual Return in %

Invested Amount
₹0
Return
₹0

Current Value
₹0

FUND SUMMARY

Benchmark

S&P BSE Healthcare TR INR

Expense Ratio

1.45%

Category Avg Expense Ratio

1.01%

Minimum Investment (Lumpsum/SIP)

₹ 5000 /₹ 1500

Lock In (Years)

No Lock-in

Fund Size

₹ 1,429.84 Cr(As on Sep, 2026)

Inception Date

Jan 01, 2013

Turnover

18.00 %

Exit Load

Period of Holding < 30 - 1%, Period of Holding = 30 days - Nil

Objective: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

UTI Healthcare Fund-Growth Option- Direct is an Equity - Sector - Healthcare fund. The fund was launched inJan 01, 2013. Its risk level is . The NAV of the fund as onOct 23, 2026 is ₹354.64. Its expense ratio is 1.45 %. The fund has an AUM of ₹1,429.84 Cr.The fund is managed byKamal Gada.
The minimum initial investment is ₹5000 in Lumpsum mode.

SUBSCRIBE TO

BUSINESS TODAY MAGAZINE

Subscribe Now

Already a subscriber?Login

DETAILED PORTFOLIO

As on Sep, 2026

EQUITY (94.12%)

DEBT (-%)

CASH (5.88%)

Allocation by Market Cap

Large Cap(18.22%)

Mid Cap(33.63%)

Small Cap(41.23%)

Industry Holdings

Drug Manufacturers Specialty Generic63.55%
Medical Care19.02%
Diagnostics Research6.53%
Biotechnology5.13%
Drug Manufacturers Major4.10%
Medical Instruments Supplies1.14%

Stock Holdings

Sun Pharmaceuticals Industries Ltd7.62%
Divi's Laboratories Ltd6.15%
Dr Reddy's Laboratories Ltd5.24%
Ajanta Pharma Ltd4.81%
Gland Pharma Ltd4.06%
Alkem Laboratories Ltd3.70%

PERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.

Consistency
i
It represents the consistency of a fund in beating its benchmark.
Downside Risk
i
Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
Risk Adjusted Return
i
Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
Volatility
i
Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
Upside Capture Ratio
i
Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
Downside Capture Ratio
i
Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

PEER ANALYSIS

card
table

Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

TOP FUNDS FROM THIS AMC

card
table

Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

ABOUT THE AMC

UTI Asset Management Co Ltd

UTI Asset Management Co Ltd manages assets worth ₹ 3,62,289.18 crores. It’s current offering of mutual fund schemes includes 36 equity, 37 debt and 8 hybrid schemes.

Phone

+91-22-6678 6666

pms_care@uti.co.in

AUM

₹ 3,62,289.18 Cr (

As on Sep 30, 2026

)

Address

PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 Mumbai,400051

FAQs

What is the category of UTI Healthcare Fund-Growth Option- Direct ?

The category of UTI Healthcare Fund-Growth Option- Direct is Equity - Sector - Healthcare

What is the current NAV of UTI Healthcare Fund-Growth Option- Direct ?

The current NAV of UTI Healthcare Fund-Growth Option- Direct as on Oct 23, 2026 is ₹354.64

How safe is UTI Healthcare Fund-Growth Option- Direct ?

The risk level of UTI Healthcare Fund-Growth Option- Direct is Very High.

What are short term returns given by UTI Healthcare Fund-Growth Option- Direct ?

The return given by UTI Healthcare Fund-Growth Option- Direct in 1 month is -10.22%, 3 months is -4.67%, 6 months is 8.15%, and 1 year is 6.98%

What are the long term returns given by UTI Healthcare Fund-Growth Option- Direct ?

The return given by UTI Healthcare Fund-Growth Option- Direct in 3 years is 21.12% and 5 years is 14.77%.

What is the expense ratio of UTI Healthcare Fund-Growth Option- Direct ?

The expense ratio of UTI Healthcare Fund-Growth Option- Direct is 1.45%

What is the AUM of UTI Healthcare Fund-Growth Option- Direct ?

The assets under Management (AUM) of UTI Healthcare Fund-Growth Option- Direct is Rs 1,429.84 crores.

What is the minimum investment in UTI Healthcare Fund-Growth Option- Direct ?

The minimum Lumpsum investment in UTI Healthcare Fund-Growth Option- Direct is ₹5,000.00 and the minimum SIP investment in UTI Healthcare Fund-Growth Option- Direct is ₹1,500.00

What is the asset allocation of UTI Healthcare Fund-Growth Option- Direct?

UTI Healthcare Fund-Growth Option- Direct has an exposure of 94.12% in Equity and 5.88% in Cash & Money Market Securities